Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compare the Hemoglobin and Hematocrit Variability Between Once & Three Times Weekly Erythropoietin Therapy for the Anemia in Patients With Maintenance Dialysis

NCT01111630 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT01111630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01111630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compare the Hemoglobin and Hematocrit Variability Between Once & Three Times Weekly Erythropoietin Therapy for the Anemia in Patients With Maintenance Dialysis
Lead sponsor
JW Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2014
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia, chronic renal failure